Skip to content

Author

P. Gollapalli

We have 4 of 60 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Integrated In Silico Analysis Reveals ABC Transporter ATP-Binding Protein as a Therapeutic Target in Helicobacter pylori

Helicobacter pylori remains a major cause of gastric diseases, while increasing antimicrobial resistance highlights the need for novel therapeutic targets. Here, we developed a comprehensive computational target-prioritization framework integrating Rosetta Stone domain-fusion analysis, subtractive genomics, metabolic...

Manish Kumar, Hulikal Shivashankar Santosh kumar, B. Kumar et al. · 0 citations
Open access Sep 2026

Exploring Challenges in Special Education: A Qualitative Analysis from the Perspectives of Special Educators in Tamil Nadu, India

Special educators play a crucial role in supporting children with disabilities, yet social, institutional, and policy-related challenges shape their professional experiences. This study explored the lived experiences and perceived challenges of special educators in Tamil Nadu, India. A qualitative descriptiv...

Harishma Ramesh, P. Gollapalli, R. Sivakumar et al. · 0 citations
Open access Sep 2026

UPLC-MS metabolite profiling and antioxidant efficacy of Neopestalotiopsisclavispora isolated from Oroxylum indicum (L.) Kurz Stem Bark

Endophytic fungi represent a valuable source of bioactive compounds with diverse pharmacological properties. In this study, we explored the antioxidant potential of secondary metabolites produced by Neopestalotiopsis clavispora (N.clavispora), an endophytic fungus isolated from Oroxylum indicum Kurz stem bark. N.clavis...

Sushma Swaroopa, Amshumala Bhoothakallu Lolajaksha, T. Gnanasekaran et al. · 0 citations
Aug 2026

Targeting methyl-accepting chemotaxis transmembrane sensory protein inhibits Helicobacter pylori autoinducer-2 quorum sensing system

Findings suggest that Withaferin A and Obacunone could serve as promising therapeutic agents against H. pylori infections by disrupting quorum sensing and biofilm formation, thus addressing the challenge of antibiotic resistance in this pathogen.

Thejaswi Bhat, Manish Kumar, T. Gnanasekaran et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.